How to investigate levels of Adherence to antiretroviral ... - INRUD
How to investigate levels of Adherence to antiretroviral ... - INRUD
How to investigate levels of Adherence to antiretroviral ... - INRUD
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>How</strong> <strong>to</strong> Investigate <strong>Adherence</strong> <strong>to</strong> Antiretroviral Treatment:<br />
An Indica<strong>to</strong>r-Based Approach<br />
You will be taken <strong>to</strong> the Country Cus<strong>to</strong>mization sheet. It looks like this:<br />
Facility Types Regions Facility Management Supply Sources Location Name ADULTS ARV First Line Abbreviation CHILDREN ARV First Line Abbreviation Drugs for Opportunistic Infections<br />
Teaching Hospital Northern Government Gov Government Gov Urban Lamivudine 150mg tab 3TC Efavirenz 50 mg or 100mg tab EFV Cotrimoxazole 480 mg or 960 mg tab<br />
TH 1 1 1<br />
Referral hospital RH Southern Private Priv Global Fund GF Rural 2 Stavudine 40 mg tab D4T 2 Efavirenz 30mg/ml syrup EFV 2 Cotrimoxazole 240mg/5ml susp<br />
Zonal Hospital ZH Eastern Mission FBO PEPFAR PEP 3 Stavudine 30 mg tab D4T 3 Nevirapine 10mg/ml syrup NVP 3 Fluconazole 150 mg or 200 mg tab<br />
District Hospital DH Western Other NGO NGO NGO NGO 4 Nevirapine 200 mg tab NVP 4 Lamivudine 10mg/ml syrup 3TC 4 Miconazole Gel<br />
Other Hospital OH Central Other Other Other Other 5 Efavirenz 200 mg tab EFV 5 Zidovudine 100 mg tab ZDV 5 Erythromycin 250 mg or 500 mg tab<br />
Health Center or Clinic HC 6 Efavirenz 600 mg tab EFV 6 Zidovudine 10 mg/ml syrup ZDV 6 Nystatin 10,000 IU/ml oral drops<br />
7 ZDV 300 mg tab +3TC 450 mg tab ZDV,3TC 7 Stavudine 15mg tab D4T 7 Acyclovir 200 mg tab<br />
8 8 Stavudine 20 mg tab D4T 8 Acyclovir 5% Cream<br />
9 9 Stavudine 1mg/ml syrup D4T 9 Folic Acid 5mg tab<br />
10 10 10<br />
7 9 9<br />
Make changes <strong>to</strong> the columns as you wish <strong>to</strong> make it most appropriate for your location. In<br />
particular, the medicine lists may need <strong>to</strong> be compiled according <strong>to</strong> local standard treatment<br />
guidelines.<br />
When maintaining the data in this sheet, please ensure that you only modify data within the<br />
designated boundaries.<br />
Adapting other forms<br />
There are a number <strong>of</strong> forms that you may wish <strong>to</strong> consider for cus<strong>to</strong>mization. The full list is<br />
available in Appendix 2E. The forms may need adapting for the particular circumstances<br />
being surveyed. The exit interview questions will need <strong>to</strong> be translated in<strong>to</strong> the appropriate<br />
local languages. This can be done during data collection training. Exit interview forms are<br />
listed separately in the appendix.<br />
Saving and exiting<br />
When you have completed cus<strong>to</strong>mizing the data, save your changes <strong>to</strong> the template. Do this<br />
by clicking on the save icon in the banner:<br />
36